Hassan, Dimokrat
Versmissen, Jorie
Hek, Karin
van Dijk, Liset
van den Bemt, Patricia M. L. A.
Funding for this research was provided by:
Innovatiefonds Zorgverzekeraars
Article History
Received: 3 June 2022
Accepted: 10 October 2022
First Online: 9 November 2022
Declarations
:
: The study was approved by the Erasmus MC medical ethical review committee (MEC-2019–0197).An Informed Consent (IC) was obtained for all patients, wherein patients give their explicit consent for study participation.The authors confirm that all methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.No information will be spread or published that can be traced back to the subject’s identity.
: LvD received funding from TEVA Pharmaceuticals and Biogen for studies not related to this study.All other authors declare that they have no competing interests.